Loading data for VVOS — first visit, this takes a few seconds.
Vivos Therapeutics, Inc. (VVOS)
NasdaqCM: VVOS
· 实时价格 · USD
0.18
+0.01 (5.88%)
收盘价： Sep 11, 2026, 3:59 PM
0.18
-3.08%
盘后: 7:56 PM
股价、关键数字和最新消息，都在这一页。
Vivos Therapeutics, Inc.（VVOS）股价、分析与数据
6.70% (1D)
| 买价 | 0.18 |
| 市值 | 3.65M |
| 营收（TTM） | 20.9M |
| 净利润（TTM） | -25.5M |
| 6.00 | |
| -1.88 | |
| n/a | |
| -0.22 | |
| 市净率（TTM） | -2.16 |
| 市销率（TTM） | 0.17 |
| 财报日期 | Apr 15, 2026 |
| 卖价 | 0.18 |
| 成交量 | 2,637,961 |
| 20日均量 | 11,640,825 |
| 开盘价 | 0.16 |
| 前收盘价 | 0.17 |
| 日内区间 | 0.16 - 0.18 |
| 52周区间 | 0.16 - 3.82 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 VVOS
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers V...
公司完整简介财报意外
Vivos Therapeutics 已于 Aug 14, 2026 发布季度财报：
- 营收为 $5.15M 低于预期 $0, ， 34.90% 同比增长.
- 每股收益为 -0.31 超出预期 0.08, ， 43.64% 同比增长.
第 1 页，共 2 页